Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comorbidities and sex differences in chronic heart failure of ischemic etiology

View through CrossRef
Abstract Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF). However, it is unknown whether the prevalence of comorbidities differs between heart failure with preserved ejection fraction, mildly reduced ejection fraction, and reduced ejection fraction in men and women. Methods: We examined 216 patients with chronic heart failure, whose main etiological factor was ischemic heart disease. We studied gender differences and the prevalence of cardiac and extracardiac comorbidities based on the left ventricular ejection fraction. Results: Chronic heart failure of ischemic etiology was significantly more common in men than in women, with a prevalence of 68.1% and 31.9%, respectively. Moreover, women were older than men at the time of hospitalization. Arterial hypertension was significantly more frequent among patients with heart failure with preserved ejection fraction, with a prevalence of 92% (p<0.05). Men are more predisposed to heart failure with reduced ejection fraction, while women predominate in heart failure with preserved ejection fraction. Extracardiac comorbidities among patients with heart failure with reduced ejection fraction were represented by chronic obstructive pulmonary disease (13.1%), congestive pneumonia (6.6%), and a history of stroke or transient ischemic attack (11.5%). Patients with heart failure with mildly reduced ejection fraction were more likely to have nonalcoholic fatty liver disease (51.9%), as well as renal and thyroid dysfunction (27.1% and 24.3%, respectively), compared to patients with preserved ejection fraction. Conclusions: The results obtained from this study confirm and supplement the existing data regarding the prevalence of chronic heart failure, gender differences, and the impact of comorbidities on the clinical status and prognosis of patients with chronic heart failure.
Title: Comorbidities and sex differences in chronic heart failure of ischemic etiology
Description:
Abstract Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF).
However, it is unknown whether the prevalence of comorbidities differs between heart failure with preserved ejection fraction, mildly reduced ejection fraction, and reduced ejection fraction in men and women.
Methods: We examined 216 patients with chronic heart failure, whose main etiological factor was ischemic heart disease.
We studied gender differences and the prevalence of cardiac and extracardiac comorbidities based on the left ventricular ejection fraction.
Results: Chronic heart failure of ischemic etiology was significantly more common in men than in women, with a prevalence of 68.
1% and 31.
9%, respectively.
Moreover, women were older than men at the time of hospitalization.
Arterial hypertension was significantly more frequent among patients with heart failure with preserved ejection fraction, with a prevalence of 92% (p<0.
05).
Men are more predisposed to heart failure with reduced ejection fraction, while women predominate in heart failure with preserved ejection fraction.
Extracardiac comorbidities among patients with heart failure with reduced ejection fraction were represented by chronic obstructive pulmonary disease (13.
1%), congestive pneumonia (6.
6%), and a history of stroke or transient ischemic attack (11.
5%).
Patients with heart failure with mildly reduced ejection fraction were more likely to have nonalcoholic fatty liver disease (51.
9%), as well as renal and thyroid dysfunction (27.
1% and 24.
3%, respectively), compared to patients with preserved ejection fraction.
Conclusions: The results obtained from this study confirm and supplement the existing data regarding the prevalence of chronic heart failure, gender differences, and the impact of comorbidities on the clinical status and prognosis of patients with chronic heart failure.

Related Results

Assessing survival time of heart failure patients: using Bayesian approach
Assessing survival time of heart failure patients: using Bayesian approach
AbstractHeart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including...
COVID impact on pattern of ischemic heart disease in comparable period
COVID impact on pattern of ischemic heart disease in comparable period
Aim: To compare the impact of COVID-19 on pattern of Ischemic Heart Disease in comparable period by assessing the incidence, severity of symptoms and in-hospital mortality of Ische...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...

Back to Top